Development and qualification of a NGS assay for control of vector genome integrity of AAV9 drug products
Time: 10:30 am
day: Track B - Day 1 AM
Details:
- Next Gen Sequencing Assay Applications
- Vector Genome Integrity of AAV9, challenges and opportunities
